Shed syndecan-1 mediates aggregation and spreading of myeloma cells

被引：0
|
作者：
Stanley, MJ
Liu, W
Lander, AD
Sanderson, RD
机构：
[1] UNIV ARKANSAS MED SCI HOSP,DEPT PATHOL,LITTLE ROCK,AR 72205
[2] UNIV CALIF IRVINE,DEPT DEV & CELL BIOL,IRVINE,CA 92717
来源：
MOLECULAR BIOLOGY OF THE CELL | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2283 / 2283
页数：1
相关论文
共 50 条
  • [21] Soluble syndecan-1 promotes growth of myeloma tumors in vivo
    Yang, Y
    Yaccoby, S
    Liu, W
    Langford, JK
    Pumphrey, CY
    Theus, A
    Epstein, J
    Sanderson, RD
    BLOOD, 2002, 100 (02) : 610 - 617
  • [22] Syndecan-1 is a key multifunctional regulator of myeloma pathobiology.
    Dhodapkar, M
    Abe, E
    Lacy, M
    Theus, A
    Langford, K
    Barlogie, B
    Sanderson, R
    BLOOD, 1997, 90 (10) : 2618 - 2618
  • [23] Disseminated growth of myeloma tumors is regulated by heparanase and syndecan-1
    Khotskaya, Yekaterina
    Suva, Larry
    Sanderson, Ralph
    CANCER RESEARCH, 2009, 69
  • [24] Syndecan-1 signals independently of β1 integrins during Raji cell spreading
    Lebakken, CS
    McQuade, KJ
    Rapraeger, AC
    EXPERIMENTAL CELL RESEARCH, 2000, 259 (02) : 315 - 325
  • [25] Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
    Purushothaman, Anurag
    Uyama, Toru
    Kobayashi, Fumi
    Yamada, Shuhei
    Sugahara, Kazuyuki
    Rapraeger, Alan C.
    Sanderson, Ralph D.
    BLOOD, 2010, 115 (12) : 2449 - 2457
  • [26] Shed syndecan-1 drives tumor progression by binding to the cell surface and translocating to the nucleus
    Stewart, Mark
    Ramani, Vishnu
    Sanderson, Ralph
    FASEB JOURNAL, 2013, 27
  • [27] Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma
    Derksen, PWB
    Keehnen, RMJ
    Evers, LM
    van Oers, MHJ
    Spaargaren, M
    Pals, ST
    BLOOD, 2002, 99 (04) : 1405 - 1410
  • [28] Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
    Wang, X.
    Zuo, D.
    Chen, Y.
    Li, W.
    Liu, R.
    He, Y.
    Ren, L.
    Zhou, L.
    Deng, T.
    Wang, X.
    Ying, G.
    Ba, Y.
    BRITISH JOURNAL OF CANCER, 2014, 111 (10) : 1965 - 1976
  • [29] Disruption of the Syndecan-1/Integrin Axis is a Novel Target for Myeloma Therapy
    Yang, Y.
    Ritchie, J. P.
    Ell, B.
    Rapraeger, A. C.
    Sanderson, R. D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S64 - S64
  • [30] Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer
    X Wang
    D Zuo
    Y Chen
    W Li
    R Liu
    Y He
    L Ren
    L Zhou
    T Deng
    X Wang
    G Ying
    Y Ba
    British Journal of Cancer, 2014, 111 : 1965 - 1976
12345